APA

Boghaert E. R., Sridharan L., Khandke K. M., Armellino D., Ryan M. G., Myers K., Harrop R., Kunz A., Hamann P. R., Marquette K., Dougher M., DiJoseph J. F. & Damle N. K. (20080320). The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin. : International journal of oncology.

Chicago

Boghaert E R, Sridharan L, Khandke K M, Armellino D, Ryan M G, Myers K, Harrop R, Kunz A, Hamann P R, Marquette K, Dougher M, DiJoseph J F and Damle N K. 20080320. The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin. : International journal of oncology.

Harvard

Boghaert E. R., Sridharan L., Khandke K. M., Armellino D., Ryan M. G., Myers K., Harrop R., Kunz A., Hamann P. R., Marquette K., Dougher M., DiJoseph J. F. and Damle N. K. (20080320). The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin. : International journal of oncology.

MLA

Boghaert E R, Sridharan L, Khandke K M, Armellino D, Ryan M G, Myers K, Harrop R, Kunz A, Hamann P R, Marquette K, Dougher M, DiJoseph J F and Damle N K. The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin. : International journal of oncology. 20080320.